High Persister Mutants in Mycobacterium tuberculosis.

Area of Science:

• Microbiology
• Molecular Biology
• Genetics

Background:

• Mycobacterium tuberculosis forms drug-tolerant persister cells, a key factor in treatment recalcitrance.
• The precise mechanisms underlying M. tuberculosis persister formation remain largely unknown.
• Persister cells are metabolically dormant and survive bactericidal antibiotics.

Purpose of the Study:

• To elucidate the genetic and molecular mechanisms of Mycobacterium tuberculosis persister cell formation.
• To identify genes and pathways associated with high persister phenotypes.
• To compare in vitro-generated high persister mutants with naturally occurring high persister clinical isolates.

Main Methods:

• Selection and characterization of high persister (hip) mutants in vitro.
• Whole genome sequencing and transcriptome analysis of hip mutants.
• Identification and characterization of clinical M. tuberculosis isolates with high persister levels.
• Comparative analysis of in vitro hip mutants and clinical isolates.

Main Results:

• Genes implicated in lipid biosynthesis, carbon metabolism, toxin-antitoxin systems, and transcriptional regulation were identified as candidate persister genes.
• Clinical isolates exhibiting high persister phenotypes showed increased ex vivo survival compared to low persister isolates.
• Multiple pathways appear to contribute to M. tuberculosis persister formation.

Conclusions:

• High persister mutants and clinical isolates provide insights into the complex mechanisms of Mycobacterium tuberculosis persister formation.
• Identified genes and pathways represent potential targets for overcoming drug tolerance in tuberculosis.
• Hip mutants may play a significant role in the persistence and recalcitrance of tuberculosis infections.